Treace Announces Participation in the Stifel 2021 Virtual Healthcare Conference

PONTE VEDRA, Fla., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of hallux valgus (commonly known as bunions), today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in a virtual fireside chat at the Stifel 2021 Virtual Healthcare Conference on Monday, November 15, 2021, beginning at approximately 9:20 am ET.]]>Read More...

To receive a free e-mail notification whenever TREACE MEDICAL CONCEPTS, INC. makes a similar move, sign up!

Other recent filings from the company include the following:

TREACE MEDICAL CONCEPTS, INC. director just disposed of 75,000 shares - Jan. 20, 2022
Treace Medical Concepts Provides 2021 Preliminary Sales Results - Jan. 12, 2022
SVP of TREACE MEDICAL CONCEPTS, INC. just cashed-in 47,700 options - Jan. 12, 2022
CIBC Private Wealth Group, LLC just provided an update on share ownership of TREACE MEDICAL CONCEPTS, INC. - Jan. 7, 2022
SVP of TREACE MEDICAL CONCEPTS, INC. just cashed-in 2,300 options - Jan. 5, 2022

Auto Refresh

Feedback